EcoR1 Capital, LLC's Net Worth
$0
Who is EcoR1 Capital, LLC?
EcoR1 Capital, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Odonate Therapeutics, Inc., Nuvation Bio Inc., PROTHENA CORP PUBLIC LTD CO, Panacea Acquisition Corp. II, Celladon Corp, Voyager Therapeutics, Inc., ANAPTYSBIO, INC, Surface Oncology, Inc., Corvus Pharmaceuticals, Inc., Zymeworks Inc., Akouos, Inc., Mersana Therapeutics, Inc., TScan Therapeutics, Inc., Graphite Bio, Inc., GENVEC INC, Tango Therapeutics, Inc., Mirati Therapeutics, Inc., and Adaptimmune Therapeutics PLC.
SEC CIK
EcoR1 Capital, LLC's CIK is 0001587114
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Odonate Therapeutics, Inc. (ODTC) Snapshot price: $17050
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -50.00% | -5.70M |
$1.66 | -$9,432,401.41 | 5.7M |
Dec 1 - Dec 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nuvation Bio Inc. (NUVB) Snapshot price: $2.85
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +72.17% | 5.31M |
$1.26 | $6,692,265.10 | 12.67M |
Sep 19 - Sep 21
| |||
Form 4
| +72.17% | 5.31M |
$1.26 | $6,692,265.10 | 12.67M |
Feb 19 - Feb 21
| |||
Form 4
| +3.07% | 488.11K |
$8.89 | $4,589,360.93 | 16.41M |
Mar 31 - Nov 24
| |||
Form 4
| +5.89% | 464.5K |
$9.89 | $4,594,593.90 | 8.35M |
Apr 9 - Apr 13
| |||
Form 4
| +162.95% | 12.86M |
$10.00 | $25,000,000.00 | 20.75M |
Feb 10
| |||
Form 4
|
∞
| 390K |
$10.00 | $3,900,000.00 | 390K |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROTHENA CORP PUBLIC LTD CO (PRTA) Snapshot price: $20.33
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$29.02 |
—
| 23.17M |
May 5
| |||
Form 4
| +2.66% | 300K |
$37.50 | $11,250,300.00 | 11.58M |
Jan 12
| |||
Form 4
| +2.27% | 250K |
$30.00 | $7,500,000.00 | 11.28M |
Jun 18
| |||
Form 4
| +8.61% | 875K |
$20.75 | $18,156,250.00 | 11.03M |
Mar 24
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +0.55% | 55.2K |
$21.24 | $1,172,384.64 | 10.16M |
Feb 23 - Feb 24
| |||
Form 4/A
| +0.44% | 44.1K |
$23.65 | $1,043,075.25 | 10.1M |
Feb 18
| |||
Form 4
| +0.44% | 44.1K |
$3.68 | $162,102.78 | 10.1M |
Feb 18
| |||
Form 4
| +6.72% | 633.34K |
$21.56 | $13,657,269.95 | 10.06M |
Feb 12 - Feb 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Panacea Acquisition Corp. II No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -545.00K |
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
∞
| 545K |
$10.00 | $5,450,000.00 | 545K |
Apr 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Celladon Corp (EIGR) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||